The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000020.3(ACVRL1):c.500C>G (p.Ser167Cys)

CA384899215

1744752 (ClinVar)

Gene: ACVRL1
Condition: telangiectasia, hereditary hemorrhagic, type 2
Inheritance Mode: Autosomal dominant inheritance
UUID: 5fd3aaea-c7a8-42e8-a6e4-418a60b6240f
Approved on: 2024-03-15
Published on: 2024-03-15

HGVS expressions

NM_000020.3:c.500C>G
NM_000020.3(ACVRL1):c.500C>G (p.Ser167Cys)
NC_000012.12:g.51913745C>G
CM000674.2:g.51913745C>G
NC_000012.11:g.52307529C>G
CM000674.1:g.52307529C>G
NC_000012.10:g.50593796C>G
NG_009549.1:g.11328C>G
ENST00000547400.6:c.355+395C>G
ENST00000551576.6:c.500C>G
ENST00000552678.2:c.500C>G
ENST00000388922.9:c.500C>G
ENST00000388922.8:c.500C>G
ENST00000419526.6:c.104-694C>G
ENST00000547400.5:c.355+395C>G
ENST00000550683.5:c.542C>G
NM_000020.2:c.500C>G
NM_001077401.1:c.500C>G
NM_001077401.2:c.500C>G

Uncertain Significance

Met criteria codes 3
PM2_Supporting PP3 PS4_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Hemorrhagic Telangiectasia Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ACVRL1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Hemorrhagic Telangiectasia VCEP
The NM_000020.3: c.500C>G variant in ACVRL1 is a missense variant predicted to cause substitution of serine by cysteine at amino acid 167 (p.Ser167Cys). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant has been reported in a proband with a phenotype consistent of HHT (PS4_Supporting; PMID: 32300199, Internal lab contributors). The computational splicing predictor SpliceAI gives a score of 0.84 for donor loss, predicting that the variant disrupts the donor splice site of intron 4 of ACVRL1 (PP3). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PM2_Supporting, PS4_Supporting, PP3 (specification version 1.0.0; 1/4/2024).
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PP3
The computational splicing predictor SpliceAI gives a score of 0.84 for donor loss, predicting that the variant disrupts the donor splice site of intron 4 of ACVRL1 (PP3).
PS4_Supporting
This variant has been reported in a proband with a phenotype consistent of HHT (PS4_Supporting; PMID: 32300199, Internal lab contributors).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.